-
If you blinked, you may have missed a recent wave of global AI commitments, a notable consensus in the chilliest international climate since the Cold War.
-
Presidents are sometimes immune from criminal prosecution, but only in limited circumstances. Trump’s case doesn’t come close.
-
What happens next in the Fulton County election interference case?
-
Due to gender-based discrimination, women politicians often lead as “iron ladies” rather than peacemakers—eschewing, not pursuing, peace with foreign adversaries.
-
Listen to this week's episode of Trump's Trials and Tribulations
-
Your weekly summary of everything on the site.
-
To improve hate crime statistics, Congress should amend existing legislation, not impose hate crime reporting mandates.
-
The unanimous decision in Lindke v. Freed marks a new weigh-in by the Supreme Court on what state officials can do on their social media accounts.
-
Elon Musk endorsed a dangerous right-wing conspiracy theory accusing the FBI of controlling the white nationalist group, Patriot Front.
-
The latest edition of the Seriously Risky Business cybersecurity newsletter, now on Lawfare.
-
G7 states could loan Russia’s frozen central bank reserves to Ukraine. Is this legally feasible?
-
Benjamin Wittes and Anna Bower will discuss the order at 3pm
-
Judge McAfee found that the defendants failed to establish an “actual conflict of interest.”
-
A review of Geoffrey Berman, “Holding the Line: Inside the Nation's Preeminent US Attorney's Office and Its Battle with the Trump Justice Department” (Penguin Press, 2022)
-
How is the Ukraine counter-offensive faring?
-
The president said the forces would remain in Haiti as required by security conditions.
-
The dueling opinions for the 9-0 decision support two opposing interpretations on this crucial question.
-
This week, Alan Rozenshtein, Quinta Jurecic, and Scott Anderson sat down together one last time before Scott's demise to talk through the week's big national security news
-
Stopping the sale of location data on sensitive locations works well for the FTC—but not for Congress.
-
Discussing the history of CIA experiments with drugs.